Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects

Clinical trial NCT00555451 · COMPLETED

Trial details

NCT number: NCT00555451
Sponsor: Harbor Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Insulin Resistance

Start date: 2007-10-01
Primary completion: 2009-09-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.